| scholarly article | Q13442814 |
| P50 | author | Mary J. Kwasny | Q45306281 |
| P2093 | author name string | Ali Keshavarzian | |
| Masoumeh Sikaroodi | |||
| Patrick M Gillevet | |||
| Ece A Mutlu | |||
| Huzefa Rangwala | |||
| Phillip A Engen | |||
| Ammar Naqvi | |||
| Cynthia K Lau | |||
| P2860 | cites work | Application of ecological network theory to the human microbiome | Q21342795 |
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| A core gut microbiome in obese and lean twins | Q24649648 | ||
| Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis | Q24652503 | ||
| Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences | Q29547172 | ||
| Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy | Q29547619 | ||
| Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
| PyNAST: a flexible tool for aligning sequences to a template alignment | Q29616628 | ||
| The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing | Q30829701 | ||
| Statistical methods for detecting differentially abundant features in clinical metagenomic samples | Q33429043 | ||
| Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data | Q33497123 | ||
| Clustering of highly homologous sequences to reduce the size of large protein databases | Q33941836 | ||
| Microbial community profiling for human microbiome projects: Tools, techniques, and challenges | Q34017154 | ||
| Gastroesophageal variceal hemorrhage | Q34362718 | ||
| Bacterial biofilms in the human gastrointestinal tract | Q34980386 | ||
| Diabetes mellitus and alcohol | Q35834309 | ||
| Network-based modeling of the human gut microbiome | Q36926180 | ||
| Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats | Q36934053 | ||
| Quantitative assessment of the human gut microbiome using multitag pyrosequencing | Q37108408 | ||
| Patients with alcohol problems | Q41707148 | ||
| Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. | Q42050277 | ||
| Nitric oxide production by monocytes in alcoholic liver disease | Q42458325 | ||
| Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. | Q43767987 | ||
| Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis | Q44419382 | ||
| Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis | Q44880291 | ||
| Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. | Q51044577 | ||
| Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. | Q51998225 | ||
| Characterization of fecal microbial communities in patients with liver cirrhosis. | Q54372904 | ||
| Epidemiology of alcoholic liver disease | Q68135451 | ||
| Endotoxemia, encephalopathy, and mortality in cirrhotic patients | Q69710492 | ||
| Antibiotics prevent liver injury in rats following long-term exposure to ethanol | Q72371146 | ||
| Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) | Q72392661 | ||
| P433 | issue | 9 | |
| P921 | main subject | alcoholism | Q15326 |
| microbiome | Q1330402 | ||
| P304 | page(s) | G966-78 | |
| P577 | publication date | 2012-01-12 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Colonic microbiome is altered in alcoholism | |
| P478 | volume | 302 |
| Q104111311 | A biological framework for emotional dysregulation in alcohol misuse: from gut to brain |
| Q36189178 | A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol |
| Q93077579 | A potential role for the gut microbiome in substance use disorders |
| Q61804548 | A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers |
| Q55399929 | A tale of two institutions. |
| Q98771133 | Abnormal Food Timing Promotes Alcohol-Associated Dysbiosis and Colon Carcinogenesis Pathways |
| Q33610049 | Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals |
| Q92846258 | Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis |
| Q38711759 | Alcohol Metabolism and Oesophageal Cancer: A Systematic Review of the Evidence |
| Q42334010 | Alcohol and Gut-Derived Inflammation |
| Q58541855 | Alcohol and narcotics use in inflammatory bowel disease |
| Q26778947 | Alcohol and the Intestine |
| Q40235896 | Alcohol consumption and risk of infection after a variceal bleeding in low-risk patients |
| Q54206867 | Alcohol enhances symptoms and propensity for infection in inflammatory bowel disease patients and a murine model of DSS-induced colitis. |
| Q42778067 | Alcohol feeding in mice promotes colonic hyperpermeability and changes in colonic organoid stem cell fate |
| Q35159476 | Alcohol induced alterations to the human fecal VOC metabolome |
| Q90193402 | Alcohol or Gut Microbiota: Who Is the Guilty? |
| Q91045563 | Alcohol, liver disease and the gut microbiota |
| Q92565635 | Alcohol-induced changes in the gut microbiome and metabolome of rhesus macaques |
| Q26783558 | Alcoholic Liver Disease: Role of Cytokines |
| Q26769970 | Alcoholic Liver Disease: Update on the Role of Dietary Fat |
| Q38381594 | Alcoholic liver disease: mechanisms of injury and targeted treatment |
| Q27025627 | Alcoholic liver disease: the gut microbiome and liver cross talk |
| Q37118760 | Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption |
| Q34508873 | Alterations of the gut microbiome and metabolome in alcoholic liver disease |
| Q90754502 | Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men |
| Q35898344 | Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis. |
| Q35077209 | Altered profile of human gut microbiome is associated with cirrhosis and its complications |
| Q91636218 | Amelioration of Alcohol Induced Gastric Ulcers Through the Administration of Lactobacillus plantarum APSulloc 331261 Isolated From Green Tea |
| Q89972146 | An empirically derived method for measuring human gut microbiome alpha diversity: Demonstrated utility in predicting health-related outcomes among a human clinical sample |
| Q36105508 | Antibiotics as deep modulators of gut microbiota: between good and evil. |
| Q55072172 | Antimicrobial-Induced Cytopenia and Bone Marrow Hypocellularity in Patients with Cirrhosis. |
| Q88450736 | Are Probiotics Effective in Targeting Alcoholic Liver Diseases? |
| Q35125974 | Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation |
| Q60047414 | Bacterial infections among patients with psychiatric disorders: Relation with hospital stay, age, and psychiatric diagnoses |
| Q47654303 | Beneficial Effect of Alcohol Withdrawal on Gut Permeability and Microbial Translocation in Patients with Alcohol Use Disorder. |
| Q90274929 | Bile Acids as Metabolic Regulators and Nutrient Sensors |
| Q90583025 | Binge Drinking's Effects on the Body |
| Q48191856 | Biological Systems Are a Common Link Between Alcohol Use Disorder and Co-Occurring Psychiatric and Medical Conditions |
| Q37384997 | CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis |
| Q35101186 | Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics |
| Q35947349 | Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? |
| Q63816416 | Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption |
| Q55255571 | Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. |
| Q28082228 | Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction |
| Q33723506 | Chronic alcohol overconsumption may alter gut microbial metabolism: a retrospective study of 719 13C-D-xylose breath test results |
| Q51278536 | Chronic alcoholics retain dyspeptic symptoms, pan-enteric dysmotility, and autonomic neuropathy before and after abstinence. |
| Q43484224 | Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. |
| Q64999497 | Chronic heavy drinking drives distinct transcriptional and epigenetic changes in splenic macrophages. |
| Q35607146 | Circadian rhythms, alcohol and gut interactions. |
| Q40201660 | Clostridium difficile extraintestinal abscess: a rare complication. |
| Q36309525 | Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation |
| Q96231888 | Combined alcoholic and non-alcoholic steatohepatitis |
| Q34256050 | Comparing the effects of acute alcohol consumption in germ-free and conventional mice: the role of the gut microbiota |
| Q57101414 | Concurrent gut transcriptome and microbiota profiling following chronic ethanol consumption in nonhuman primates |
| Q35530189 | Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? |
| Q45067732 | Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis |
| Q36038296 | Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review |
| Q92537172 | Diet in Parkinson's Disease: Critical Role for the Microbiome |
| Q89551039 | Dietary Synbiotic Supplementation Protects Barrier Integrity of Hepatocytes and Liver Sinusoidal Endothelium in a Mouse Model of Chronic-Binge Ethanol Exposure |
| Q28077273 | Dietary and Lifestyle Factors Associated with Colorectal Cancer Risk and Interactions with Microbiota: Fiber, Red or Processed Meat and Alcoholic Drinks |
| Q94588825 | Disrupted Diurnal Oscillation of Gut-Derived Short Chain Fatty Acids in Shift Workers Drinking Alcohol: Possible Mechanism for Loss of Resiliency of Intestinal Barrier in Disrupted Circadian Host |
| Q28534128 | Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation |
| Q47588084 | Diurnal variations in intestinal barrier integrity and liver pathology in mice: implications for alcohol binge. |
| Q40727491 | Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West? |
| Q36997204 | Ecophysiological consequences of alcoholism on human gut microbiota: implications for ethanol-related pathogenesis of colon cancer |
| Q88639670 | Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome |
| Q89399219 | Endotoxin at the Maternal-Fetal Interface in a Resource-Constrained Setting: Risk Factors and Associated Birth Outcomes |
| Q59411245 | Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention |
| Q36741674 | Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol |
| Q38118340 | Ethanol metabolism and its effects on the intestinal epithelial barrier |
| Q38639702 | Excessive alcohol consumption induces methane production in humans and rats |
| Q92447396 | Extraintestinal Clostridioides difficile Infections: Epidemiology in a University Hospital in Hungary and Review of the Literature |
| Q46253420 | Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. |
| Q36287836 | Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice |
| Q90586301 | Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia |
| Q94544811 | Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder |
| Q98241465 | Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis |
| Q33881464 | Fungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase. |
| Q64883132 | Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of the Volatile Oil of Cichorium Glandulosum Boiss et Huet and its Effects on Carbon Tetrachloride-Induced Liver Fibrosis in Rats. |
| Q35068270 | Global metabolic profiling for the study of alcohol-related disorders |
| Q30236024 | Gut Microbiota and Complications of Liver Disease |
| Q28083295 | Gut Microbiota and Host Reaction in Liver Diseases |
| Q49183637 | Gut bacteria may control development of hepatocellular carcinoma |
| Q54948497 | Gut microbial composition can differentially regulate bile acid synthesis in humanized mice. |
| Q38914215 | Gut microbiome and liver disease |
| Q52839364 | Gut microbiome and liver diseases. |
| Q27015127 | Gut microbiota and liver diseases |
| Q26864127 | Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives |
| Q34549031 | Gut microbiota, inflammation and colorectal cancer |
| Q57118234 | Gut-liver axis alterations in alcoholic liver disease: Are bile acids the answer? |
| Q39290975 | Gut-liver axis and sterile signals in the development of alcoholic liver disease |
| Q40612995 | HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients |
| Q36684848 | HIV-associated mucosal gene expression: region-specific alterations |
| Q33830030 | Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats |
| Q64244270 | Histopathological Features and Composition of Gut Microbiota in Rhesus Monkey of Alcoholic Liver Disease |
| Q27693308 | Host-microbiome interactions in alcoholic liver disease |
| Q91656797 | How does the microbiome affect liver disease? |
| Q35867582 | Human Microbiome and its Association With Health and Diseases. |
| Q36269642 | Immune dysfunction in acute alcoholic hepatitis. |
| Q46387163 | Immunoglobulin A and liver diseases. |
| Q35740865 | Implications of microbiota and bile acid in liver injury and regeneration |
| Q55252106 | Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? |
| Q92881710 | Inflammatory Biomarkers, Microbiome, Depression, and Executive Dysfunction in Alcohol Users |
| Q26778040 | Inflammatory status in human hepatic cirrhosis |
| Q26865988 | Insulin resistance in clinical and experimental alcoholic liver disease |
| Q38179779 | Interactions between the intestinal microbiome and liver diseases |
| Q27014102 | Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness |
| Q35920984 | Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation |
| Q38123531 | Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature |
| Q41661762 | Intestinal fungi contribute to development of alcoholic liver disease. |
| Q34409186 | Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity |
| Q91650386 | Intestine-Liver Axis On-Chip Reveals the Intestinal Protective Role on Hepatic Damage by Emulating Ethanol First-Pass Metabolism |
| Q40077207 | Invading beyond bounds: extraintestinal Clostridium difficile infection leading to pancreatic and liver abscesses. |
| Q49207471 | Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities |
| Q59101131 | Is there a role for probiotics in liver disease? |
| Q33715465 | Leaky Gut As a Danger Signal for Autoimmune Diseases |
| Q33828940 | Linking intestinal homeostasis and liver disease |
| Q42682576 | Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease |
| Q47868682 | Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program. |
| Q58098820 | LogMPIE, pan-India profiling of the human gut microbiome using 16S rRNA sequencing |
| Q35918478 | Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults |
| Q97597582 | MICROBIOTA REPROGRAMMING FOR TREATMENT OF ALCOHOL-RELATED LIVER DISEASE |
| Q46612133 | Major Anaerobic Bacteria Responsible for the Production of Carcinogenic Acetaldehyde from Ethanol in the Colon and Rectum. |
| Q36665120 | Maternal nutritional status as a contributing factor for the risk of fetal alcohol spectrum disorders. |
| Q91869803 | Metabolic phenotyping of the human microbiome |
| Q34551121 | Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment |
| Q35837968 | Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury |
| Q47264110 | Microbiota, a key player in alcoholic liver disease. |
| Q45069266 | Microbiota, cirrhosis, and the emerging oral-gut-liver axis |
| Q26740192 | Microbiota-based treatments in alcoholic liver disease |
| Q33855414 | Microbiota-liver axis in hepatic disease. |
| Q36409554 | Modulation of Intestinal Barrier and Bacterial Endotoxin Production Contributes to the Beneficial Effect of Nicotinic Acid on Alcohol-Induced Endotoxemia and Hepatic Inflammation in Rats |
| Q45955303 | Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice. |
| Q99712219 | Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities |
| Q37015781 | Opposing effects of alcohol on the immune system |
| Q41663528 | Organ-Organ Crosstalk and Alcoholic Liver Disease |
| Q90103844 | Paneth Cell Dysfunction Mediates Alcohol-related Steatohepatitis Through Promoting Bacterial Translocation in Mice: Role of Zinc Deficiency |
| Q38823745 | Pathogenesis of alcoholic liver disease |
| Q26749878 | Pathogenic role of the gut microbiota in gastrointestinal diseases |
| Q90469832 | Potential effect of probiotics in the treatment of breast cancer |
| Q50054205 | Preventive effects of indole-3-carbinol against alcohol-induced liver injury in mice via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms: Role of gut-liver-adipose tissue axis |
| Q26770137 | Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms |
| Q37372411 | Probiotics and liver disease |
| Q38776474 | Proceeding of the 8th Alcohol Hangover Research Group Meeting. |
| Q91925617 | Psychotropics and the Microbiome: a Chamber of Secrets… |
| Q88764776 | Publisher Correction: The gut-liver axis and the intersection with the microbiome |
| Q90377582 | Rapid Assessment of Nutrition Services in Los Angeles Substance Use Disorder Treatment Centers |
| Q95840413 | Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease |
| Q33456815 | Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome |
| Q35586895 | Review article: Alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. |
| Q48105576 | Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. |
| Q28086898 | Role of farnesoid X receptor and bile acids in alcoholic liver disease |
| Q92252696 | Role of the intestinal microbiome in liver fibrosis development and new treatment strategies |
| Q35969570 | Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease |
| Q38645789 | Starring role of toll-like receptor-4 activation in the gut-liver axis |
| Q47715055 | Stress and stability: applying the Anna Karenina principle to animal microbiomes. |
| Q35828288 | Summary of the 2014 Alcohol and Immunology Research Interest Group (AIRIG) meeting |
| Q34759068 | Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice |
| Q35921869 | Targeting Dysbiosis for the Treatment of Liver Disease |
| Q92570756 | Targeting Microbiota: What Do We Know about It at Present? |
| Q90405711 | Targeting the gut barrier for the treatment of alcoholic liver disease |
| Q37082666 | Taurocholic acid metabolism by gut microbes and colon cancer |
| Q35913803 | The Circadian Clock Mutation Promotes Intestinal Dysbiosis. |
| Q58802903 | The Effects of Alcohol and Drugs of Abuse on Maternal Nutritional Profile during Pregnancy |
| Q26773227 | The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota |
| Q57167488 | The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders |
| Q38815561 | The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer |
| Q39290933 | The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A 'Ménage à Trois'? |
| Q88650068 | The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective |
| Q26765740 | The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation |
| Q45071332 | The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. |
| Q35743960 | The gut microbiota and liver disease |
| Q35019661 | The gut microbiota and the liver: implications for clinical practice |
| Q88634168 | The gut-liver axis and the intersection with the microbiome |
| Q36310293 | The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease |
| Q39154504 | The link between inflammation, bugs, the intestine and the brain in alcohol dependence |
| Q38254456 | The role of miRNAs in alcohol-induced endotoxemia, dysfunction of mucosal immunity, and gut leakiness |
| Q34129402 | The role of microbiota in hepatic encephalopathy |
| Q89624002 | The role of the gut microbiome in chronic liver disease: the clinical evidence revised |
| Q35696171 | The role of the gut-brain axis in alcohol use disorders |
| Q42367659 | Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis |
| Q28066755 | Tiny microbes, enormous impacts: what matters in gut microbiome studies? |
| Q58766154 | Tributyrin Supplementation Protects Immune Responses and Vasculature and Reduces Oxidative Stress in the Proximal Colon of Mice Exposed to Chronic-Binge Ethanol Feeding |
| Q103805824 | Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure |
Search more.